Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL TAP Infiltration for C-Section Pain (CHOICE)
NCT03853694Phase 4Completed
- Sponsor
- Pacira BioSciences
- Start
- Mar 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in postoperative pain (3 arms), sponsored by Pacira BioSciences. Primary endpoint: Total Postsurgical Opioid Consumption Through 72 Hours. Started Mar 2019; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03853694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03853694.